Clinical and pharmacological group: & nbsp

H1-antihistamines

Included in the formulation
АТХ:

R.06.A.X   Other antihistamines for systemic use

Pharmacodynamics:

Combined drug.

Mebrogroline

Blocks H1-gistaminovye receptors, has anti-allergic, antipruritic, m-holinoblokiruyuschee, sedative effect. Reduces the swelling of the mucous membrane.

Zinc sulfate

Interacts with cells of the mucosa, compacts colloids of extracellular fluid, exudate, mucus, forming a continuous film that protects from irritation of the end of the sensory nerves. Thus, it protects the mucous membrane from inflammation and prevents the irritating effect of the mebhydrolin.

Pharmacokinetics:

Mebrogroline

After oral administration, an empty stomach is absorbed in the gastrointestinal tract up to 50%. The maximum concentration in the blood plasma is achieved in 1-2 hours. The connection with plasma proteins is 90%.

Therapeutic effect develops 15-30 minutes after the start of the procedure and lasts for 48 hours. Metabolism in the liver.

The half-life is 4 hours. Elimination by the kidneys.

Zinc sulfate

Local agent is not absorbed into the bloodstream and does not have a systemic effect on the body.

Indications:

It is used to treat acute seasonal or all-year-round allergic conjunctivitis and rhinitis.Used for hay fever, hives, eczema, insect bites.

X.J30-J39.J30   Vasomotor and allergic rhinitis

VII.H10-H13.H10.1   Acute atopic conjunctivitis

X.J30-J39.J30.1   Allergic rhinitis caused by pollen of plants

X.J30-J39.J30.2   Other seasonal allergic rhinitis

X.J40-J47.J45   Asthma

XII.L20-L30.L20.8   Other atopic dermatitis

XII.L20-L30.L29   Itching

XII.L50-L54.L50   Hives

Contraindications:

Peptic ulcer of the stomach and duodenum in the period of exacerbation, age to 1 year, pregnancy and lactation, prostatic hyperplasia, individual intolerance.

Carefully:

Epilepsy, heart rhythm disturbances, closed angle glaucoma, renal and hepatic insufficiency, pyloric stenosis, hypersensitivity.

Pregnancy and lactation:

Recommendations for FDA - Category C. Contraindicated in pregnancy and lactation.

Dosing and Administration:

Use in children

Inside after a meal, depending on the age:

up to 2 years: 50-100 mg per day;

2-5 years: 50-150 mg per day;

5-10 years: 100-200 mg per day.

over 10 years: 50-200 mg 1-2 times a day.

Adults

Inside after a meal, 50-200 mg 1-2 times a day.

The highest daily dose: 400 mg.

The highest single dose: 200 mg.

Side effects:

Central and peripheral nervous system: dizziness, drowsiness, paresthesia; paradoxical reactions in children - irritability, sleep disturbance, tremor.

Hemopoietic system: granulocythemia, agranulocytosis.

Digestive system: heartburn, nausea, dry mouth, vomiting, epigastric pain, constipation.

Sense organs: blurred vision.

urinary system: dysuria.

Allergic reactions.

Overdose:

Drowsiness, confusion, oppression of the central nervous system, coma.

Treatment is symptomatic.

Interaction:

With simultaneous application increases the inhibitory effect on the central nervous system of sedatives and ethanol.

Special instructions:

Incompatible with ethanol.

When taking the drug is not recommended driving and working with moving machinery.

Instructions
Up